Submissions from 2025
Detection of MRD positivity as an indicator of CNS relapse in AML and therapeutic approach., Sumasri Chennapragada, Vishal Devarkonda, and Hugo Akabane
Monitoring the rate and variability of somatic genomic alterations using long-read sequencing., Xingyao Chen, Hagai Ligumsky, Charlie Ambrose, Denisse Sibrian, Brian Tran, Daoud Arif, Olga Castellanos, Darren Kessner, Hanyi Luo, Mukta Ubale, Abigail Coleman, Vaidhyanathan Mahaganapathy, Thomas J Jönsson, Reva K Basho, Jerry S H Lee, Naim Matasci, and David B Agus
Thorax-encompassing multi-modality PET/CT deep learning model for resected lung cancer prognostication: A retrospective, multicenter study., Jaryd R Christie, Perrin Romine, Karen Eddy, Delphine L Chen, Omar Daher, Mohamed Abdelrazek, Richard A Malthaner, Mehdi Qiabi, Rahul Nayak, Paul Kinahan, Viswam S Nair, and Sarah A Mattonen
Phase 1b Study of Dazostinag Plus Pembrolizumab After Hypofractionated Radiotherapy in Patients With Select Advanced Solid Tumors., Benjamin T Cooper, Wade T Iams, David B Page, Yuan Yuan, Naamit K Gerber, Jason J Luke, John P Gibbs, Richard C Gregory, Kwok-Kin Wong, Jiehui Deng, Samanthi A Perera, Kai Ding, Emily R Roberts, Allison Berger, Camilla L Christensen, Erica Xin Tong, Angel E Maldonado López, Vicky A Appleman, E Jane Leonard, Alexander Parent, Yu-Chung Huang, Camden Bay, Cong Li, Neil Lineberry, Jeffrey Raizer, Daniel J Olson, and Steven J Chmura
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols., Tricia R Cottrell, Michael T Lotze, Alaa Ali, Carlo Bifulco, Christian M Capitini, Laura Q M Chow, Anthony R Cillo, Deborah Collyar, Leslie Cope, Julie Stein Deutsch, Genia Dubrovsky, Sacha Gnjatic, Denise Goh, Susan Halabi, Gary Kohanbash, Holden T Maecker, Saman Maleki Vareki, Sarah Mullin, Barbara Seliger, Janis Taube, Wim Vos, Joe Yeong, Kristin G Anderson, Tullia C Bruno, Codruta Chiuzan, Ivan Diaz-Padilla, Elizabeth Garrett-Mayer, Isabella C Glitza Oliva, Paola Grandi, Elizabeth G Hill, Brian P Hobbs, Yana G Najjar, Phyllis Pettit Nassi, Virgil H Simons, Sumit K Subudhi, Ryan J Sullivan, and Chris H Takimoto
Importance of Surgical Margins in Patients with Early-Stage Merkel Cell Carcinoma., Arthur W Cowman, Kristel Lourdault, Douglas Hanes, Sean Nassoiy, Paul Shin, Tyler Aguilar, Melanie Goldfarb, and Richard Essner
Surgical Management of Thick Primary Cutaneous Melanoma in the US., Arthur W Cowman, Kristel Lourdault, Douglas Hanes, Jessica Weiss, Sean Nassoiy, Melanie Goldfarb, and Richard Essner
Treatment, outcomes, and resource utilization among patients with metastatic breast and advanced epithelial ovarian cancer, by BRCA1/2 and HRD status., Giovanna I Cruz, Kaitlyn L Kane, Rayna K Matsuno, Connor Sweetnam, Adrienne F O Williams, Liz M Toland, Amy Stone, Anna B Berry, Monika A Izano, Liam C Lee, Jagadeswara R Earla, Thomas D Brown, Charles W Drescher, Henry G Kaplan, Smita Kothari, Arthur Sillah, and Gieira Jones
Checkpoint Immunotherapy for Melanoma - Offering Hope for Cure., Brendan Curti
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns., Narmeen Daher-Ghanem, Shay Sharon, Derrick L Tao, Zhaoyu Sun, Wesley K Rosales, Venkatesh Rajamanickam, Ryan Meng, Lakhvir Kaur, Brady Bernard, Brian D. Piening, Marcus Couey, Michael J. Gough, and Nataly Kravchenko-Balasha
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies., Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero, Catherine S Diefenbach, Daniel N Egan, Shira N Dinner, Nathalie Javidi-Sharifi, Monzr M Al Malki, Kebede H Begna, Vijaya Raj Bhatt, Sameem Abedin, Rachel J Cook, Mary C Collins, Carly Roleder, Edward C Dominguez, Prabhu Rajagopalan, Sandra E Wiley, Richard G Ghalie, and Alexey V Danilov
ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia., Matthew S Davids, Saad S Kenderian, Ian Flinn, Brian T Hill, Michael Maris, Paolo Ghia, Michael Byrne, Nancy L Bartlett, John M Pagel, Yan Zheng, Justyna Kanska, Wangshu Zhang, Enrique Granados, and Javier Pinilla-Ibarz
Sharing data from the Human Tumor Atlas Network through standards, infrastructure and community engagement., Ino de Bruijn, Milen Nikolov, Clarisse Lau, Ashley Clayton, David L Gibbs, Elvira Mitraka, Dar'ya Pozhidayeva, Alex Lash, Selcuk Onur Sumer, Jennifer Altreuter, Kristen Anton, Mialy DeFelice, Xiang Li, Aaron Lisman, William J R Longabaugh, Jeremy Muhlich, Sandro Santagata, Subhiksha Nandakumar, Peter K Sorger, Christine Suver, Xengie Doan, Justin Guinney, Nikolaus Schultz, Adam J Taylor, Vésteinn Thorsson, Ethan Cerami, and James A Eddy
OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma., Kinjal Desai, Siyi Wanggou, Erika Luis, Heather Whetstone, Chunying Yu, Robert J Vanner, Hayden J Selvadurai, Lilian Lee, Jinchu Vijay, Julia E Jaramillo, Jerry Fan, Paul Guilhamon, Michelle Kushida, Xuejun Li, Gregory Stein, Santosh Kesari, Benjamin D Simons, Xi Huang, and Peter B Dirks
Restricted physical activity and maternal rest improve fetal growth., Greggory R DeVore, Bardo Polanco, Wesley Lee, Jeffrey Brian Fowlkes, Emma E Peek, Manesha Putra, and John C Hobbins
Approaches to overcome the current treatment plateau in immunotherapy., Anna Maria Di Giacomo, Renzo Canetta, John Connolly, Rom Leidner, Wei Zheng, Young Kim, Ramy Ibrahim, Michael Lahn, Michael Smith, Alexander Eggermont, Bernard A Fox, and Michele Maio
Perspectives on the role of "-Omics" in predicting response to immunotherapy., Anna Maria Di Giacomo, Sumit Subudhi, Wim Vos, Massimo Andreatta, Santiago Carmona, Will McTavish, Barbara Seliger, Ramy Ibrahim, Michael Lahn, Michael Smith, Alexander Eggermont, Bernard A Fox, and Michele Maio
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registry., Francesco Ditonno, Alessandro Veccia, Gabriele Bignante, Zhenjie Wu, Linhui Wang, Firas Abdollah, Alex Stephens, Giuseppe Simone, Gabriele Tuderti, Randall Lee, Daniel D Eun, Andres F Correa, Ottavio De Cobelli, Matteo Ferro, Francesco Porpiglia, Daniele Amparore, Enrico Checcucci, Antonio Tufano, Roberto Contieri, Sisto Perdonà, Raj Bhanvadia, Vitaly Margulis, Stephan Brönimann, Nirmish Singla, James R Porter, Saum Ghodoussipour, Andrea Minervini, Andrea Mari, Luca Lambertini, Alireza Ghoreifi, Omri Falik Nativ, Mark L Gonzalgo, Daniel Sidhom, Chandru P Sundaram, Reuben Ben-David, Ahmed Eraky, Reza Mehrazin, Takashi Yoshida, Hidefumi Kinoshita, Alireza Dehghanmanshadi, Soroush Rais-Bahrami, Margaret F Meagher, Dhruv Puri, Ithaar H Derweesh, Farshad S Moghaddam, Hooman Djaladat, Riccardo Bertolo, Riccardo Autorino, and Alessandro Antonelli
Impact of neoadjuvant treatment on functional outcomes after transanal total mesorectal excision (taTME)-a case series., Katherine F Donovan, Elisa Paoluzzi Tomada, Heather Carmichael, Alison Ricardo, Natalie Berger, Antoinette Bonaccorso, Karim Alavi, Karen Zaghiyan, Alessio Pigazzi, Dana Sands, Theresa DeBeche-Adams, Sami A Chadi, Elisabeth C McLemore, John H Marks, Justin A Maykel, Sherief F Shawki, Scott R Steele, Matthew Albert, Mark Whiteford, Steven D Wexner, and Patricia Sylla
Unravelling the complexity of the anti-tumor response in human solid tumors, Thomas Duhen
Unravelling the complexity of the anti-tumor response in human solid tumors, Thomas Duhen
Longitudinal Genomic Analysis to Fine-Tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients With BRAF V600-Mutant Metastatic Melanoma., Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, Marcus O Butler, Matthew H Taylor, Lucie Heinzerling, Christian U Blank, Eva Munoz-Couselo, Howard A Burris, Michael A Postow, Bartosz Chmielowski, Mark R Middleton, Carola Berking, Jessica C Hassel, Anja Heike Gesierich, Cornelia Mauch, Joseph F Kleha, Anna Polli, Allison S Harney, Alessandra di Pietro, and Paolo A Ascierto
SLC7A5 is required for cancer cell growth under arginine-limited conditions., Kyle N Dunlap, Austin Bender, Alexis Bowles, Alex J Bott, Joshua Tay, Allie H Grossmann, Jared Rutter, and Gregory S Ducker
Cancer Survivor Integrative Therapy Program Improves Physical, Metabolic and Mental Wellbeing, Gianna Durocher and Megan Wroe
Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets., Kyle Ellrott, Christopher K Wong, Christina Yau, Mauro A A Castro, Jordan A Lee, Brian J Karlberg, Jasleen K Grewal, Vincenzo Lagani, Bahar Tercan, Verena Friedl, Toshinori Hinoue, Vladislav Uzunangelov, Lindsay Westlake, Xavier Loinaz, Ina Felau, Peggy I Wang, Anab Kemal, Samantha J Caesar-Johnson, Ilya Shmulevich, Alexander J Lazar, Ioannis Tsamardinos, Katherine A Hoadley, A Gordon Robertson, Theo A Knijnenburg, Christopher C Benz, Joshua M Stuart, Jean C Zenklusen, Andrew D Cherniack, and Peter W Laird
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development., Leisha A Emens, Christine Moussion, Patrick Hwu, James L Gulley, Pamela S Ohashi, Carlo B Bifulco, and David Feltquate
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial., Ramez N Eskander, Michael W Sill, Lindsey Beffa, Richard G Moore, Joanie M Hope, Fernanda Musa, Robert S Mannel, Mark S Shahin, Guilherme H Cantuaria, Eugenia Girda, Elizabeth Lokich, Juraj Kavecansky, Charles A Leath, Lilian T Gien, Emily M Hinchcliff, Shashikant B Lele, Lisa M Landrum, Floor Backes, Roisin E O'Cearbhaill, Tareq Al Baghdadi, Emily K Hill, Premal H Thaker, Veena S John, Stephen Welch, Amanda N Fader, Matthew A Powell, and Carol Aghajanian
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non-Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial., Enriqueta Felip, Nasser Altorki, Caicun Zhou, Eric Vallieres, Tibor Csoszi, Ihor O Vynnychenko, Oleksandr Goloborodko, Achim Rittmeyer, Martin Reck, Alex Martinez-Marti, Hirotsugu Kenmotsu, Yuh-Min Chen, Antonio Chella, Shunichi Sugawara, Chenqi Fu, Marcus Ballinger, Yu Deng, Minu K Srivastava, Elizabeth Bennett, Barbara J Gitlitz, and Heather A Wakelee
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma., Robert L Ferris, Rom Leidner, Christine H Chung, Antonio Jimeno, Sylvia M Lee, Ammar Sukari, Jorge J Nieva, Juneko E Grilley-Olson, Rebecca Redman, Stuart J Wong, Victoria M Villaflor, Jamal Misleh, Friedrich Graf Finckenstein, Jeffrey Chou, Brian Gastman, Rana Fiaz, Melissa Catlett, Min Yi, and Ezra E W Cohen
Facts and Hopes: Toward the Next Quantum Leap in Melanoma., Keith T Flaherty, Andrew E Aplin, Michael A Davies, Nir Hacohen, Meenhard Herlyn, Dave Hoon, Patrick Hwu, Michal Lotem, James Mulé, Jennifer A Wargo, and David E Fisher
Signaling and transcriptional dynamics underlying early adaptation to oncogenic BRAF inhibition., Cameron T Flower, Chunmei Liu, Hui-Yu Chuang, Xiaoyang Ye, Hanjun Cheng, James R Heath, Wei Wei, and Forest M White
Editorial: A year in review: discussions in human and medical genomics., Maxim B Freidin and Jared C Roach
Comparing the performance of dynamic susceptibility contrast and arterial spin labeling for detecting residual and recurrent glioblastoma with deep learning and multishell diffusion MRI., Louis Gagnon, Diviya Gupta, George Mastorakos, Nathan White, Vanessa Goodwill, Carrie R McDonald, Thomas Beaumont, Christopher Conlin, Tyler M Seibert, Uyen Nguyen, Jona Hattangadi-Gluth, Santosh Kesari, Jessica D Schulte, David Piccioni, Divya S Bolar, Anders M Dale, Nikdokht Farid, and Jeffrey D Rudie
Avoidance of Major Vascular Injury in Transcranial Brain Tumor Surgery Using Real-Time Doppler Navigation: Technical Note and Case Series., R Justin Garling, Regin Jay Mallari, Davendran Kanesen, Byron Hontiveros, Walavan Sivakumar, Daniel F Kelly, and Garni Barkhoudarian
Manual therapy considerations for adhesive capsulitis in the breast cancer population: a clinical perspective., Diana Garrett, Gary Kearns, and Steve Karas
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer., Charles E Geyer, Michael Untch, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Norman Wolmark, Priya Rastogi, Andreas Schneeweiss, Andres Redondo, Hans H Fischer, Véronique D'Hondt, Alison Conlin, Valentina Guarneri, Irene L Wapnir, Christian Jackisch, Claudia Arce-Salinas, Peter A Fasching, Michael P DiGiovanna, John P Crown, Pia Wuelfing, Zhimin Shao, Elena Rota Caremoli, Hervé R Bonnefoi, Bryan T Hennessy, Ljiljana Stamatovic, Hugo Castro-Salguero, Adam M Brufsky, Adam Knott, Asna Siddiqui, Chiara Lambertini, Thomas Boulet, Beatrice Nyawira, Eleonora Restuccia, Sibylle Loibl, and KATHERINE Study Group
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial., Armin Ghobadi, Veronika Bachanova, Krish Patel, Jae H Park, Ian Flinn, Peter A Riedell, Carlos Bachier, Catherine S Diefenbach, Carol Wong, Cara Bickers, Lilly Wong, Deepa Patel, Jode Goodridge, Matthew Denholt, Bahram Valamehr, Rebecca L Elstrom, and Paolo Strati
Clinical Experience with URO17(®) in the Diagnosis and Surveillance of Bladder Cancer, Shahram Shawn Gholami, Mehran Movassaghi, Sasha Homayoun, and Nikhil Vasdev
Analysis of clinical, single cell, and spatial data from the Human Tumor Atlas Network (HTAN) with massively distributed cloud-based queries., David L Gibbs, Dar'ya Pozhidayeva, Yamina Katariya, Boris Aguilar, Kristen Anton, Clarisse Lau, William Jr Longabaugh, Ino de Bruijn, Alex Lash, Milen Nikolov, Jennifer Altreuter, Ashley Clayton, Aditi Gopalan, Adam J Taylor, Nikolaus Schultz, Ethan Cerami, and Vesteinn Thorsson
A Multisite Demonstration of Shared Access to Older Adults' Patient Portals., Kelly T Gleason, Catherine M DesRoches, Mingche M J Wu, Danielle Peereboom, Vadim Dukhanin, Timothy W Farrell, Matthew J Gonzales, Saloni Sharma, Supriya G Mohile, Sara Epstein, Mark A Supiano, Marianne C Parshley, David L Roth, Jennifer L Wolff, and Shared Access Project Team
Pilot Study of Plasma miRNA Signature Panel for Differentiating Single vs Multiglandular Parathyroid Disease., Melanie Goldfarb, Matias A Bustos, Jamie Moon, Katherine Jackson, Frederick R Singer, and Dave S B Hoon
Continuing De-escalation Trends: Is Adjuvant Radioactive Iodine Administration Truly Needed for Papillary Thyroid Carcinoma with Limited Cervical Disease?, Melanie Goldfarb and Nicholas Ullman
CANCER THERAPEUTIC COMPOSITIONS AND METHODS TARGETING DNASEIL3, Michael J. Gough, Marka R Crittenden, and Tiffany Blair
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma., P Grover, S N Lo, I Li, A M J Kuijpers, F Kreidieh, A Williamson, T Amaral, F Dimitriou, J Placzke, K Olino, M G Vitale, P Saiag, R Gutzmer, C Allayous, R Olofsson Bagge, J Mattsson, N Asher, T J Carter, T M Meniawy, A R Lawless, J A Czapla, L Warburton, C Gaudy-Marqueste, J J Grob, R G Collins, E Zhang, J I Kessels, B Neyns, I Mehmi, O Hamid, M Julve, A J S Furness, K A Margolin, Shaked Lev-Ari, J M Ressler, W Haque, M A Khattak, A Wicky, R Roberts-Thomson, A Arance, G Warrier, M D Schollenberger, P Parente, E Chatziioannou, E J Lipson, O Michielin, J S Weber, C Hoeller, J Larkin, M B Atkins, R Essner, D B Johnson, R J Sullivan, P Nathan, J Schachter, C Lebbe, P A Ascierto, H Kluger, P Rutkowski, R Dummer, C Garbe, P C Lorigan, E Burton, H A Tawbi, J Haanen, M S Carlino, A M Menzies, and G V Long
A Prospective, Multicenter Analysis of Recurrence-Free Survival After Sentinel Lymph Node Biopsy Decisions Influenced by the 31-GEP., J Michael Guenther, Andrew Ward, Brian J Martin, Mark Cripe, Timothy Beard, Oliver Wisco, Rohit Sharma, Stanley P Leong, Richard Essner, Joseph I Clark, John Hamner, Brenda Sickle-Santanello, and Maki Yamamoto
TGFβ limits proximal CD8+ TCR signaling via PTPN22 following strong and moderate agonism., Andrew J Gunderson, Kelley R Jordan, Tomoko Yamazaki, Hans-Peter Raué, Gwen Kramer, Nathaniel E Fox, Mark K Slifka, Michael J. Gough, Marka R Crittenden, and Kristina H Young
Longitudinal retrospective study of real-world adherence to colorectal cancer screening before and after the COVID-19 pandemic in the USA., Harsh Gupta, Robyn Ann Husa, Staci J Wendt, Ann Vita, Claire Boone, Jessica B Weiss, and Anton J Bilchik
Dostarlimab and niraparib in primary advanced ovarian cancer., A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, F Montestruc, A Redondo, M R Mirza, D Cibula, T-E Ciuleanu, L Gilbert, R Eitan, F Zagouri, S Pignata, R Glasspool, J Pfisterer, R Phaëton, C K Anderson, M Rodrigues, L Gaba, E Bakirtzi, J M Fauci, E Kalbacher, F B Musa, S Gorman, L R Duska, L Gladieff, P Braly, F Joly, J Thomes Pepin, I Ray-Coquard, and K N Moore
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers., Arielle L Heeke, Andrew Elliott, Kaitlyn O'Keefe, Chad Livasy, James T Symanowski, Meghan R Steiner, Irene M Kang, Dave S B Hoon, Philip Walker, George W Sledge, Milan Radovich, Paula R Pohlmann, Sandra M Swain, and Antoinette R Tan
Association of baseline ctDNA EGFR mutation detection with clinical outcome in the phase II RAMOSE trial assessing ramucirumab plus osimertinib versus osimertinib in EGFR mutant non-small cell lung cancer, S Heeke, Rachel Sanborn, and See full list of authors in comments
Implementation of a Traceback Testing Program for Ovarian Cancer: Findings from the FACTS Study., Nora B Henrikson, M Cabell Jonas, Paula R Blasi, Adam H Buchanan, Pim Suwannarat, Kathleen Leppig, Aaron Scrol, Tracey Leitzel, Adrienne N Deneal, Daniela Canedo, Arvind Ramaprasan, Sundeep S Basra, Jennifer Brown, Marilyn Odums, Yirui Hu, Katrina M Romagnoli, Estella Khieu, Elsa Balton, Saumya Patel, Muki Kunnmann, Dina Hassen, Jing Hao, Meredith Lewis, Rachel Schwiter, Jessica Goehringer, Heather M Ramey, Shanshan Gustafson, Katrina Hsieh, Ilene Ladd, and Alanna K Rahm
Outcomes of endoscopic management for upper tract urothelial carcinoma: A multi-center international cohort analysis., Jaime O Herrera-Caceres, Marian Wettstein, Surena F Matin, Craig Labbate, Aaron Potretzke, Rodrigo Rodriguez, Nirmish Singla, Maximilian Pallauf, William Huang, Shavy Nagpal, Nir Kleinmann, Asaf Shvero, Alexander Small, Benjamin Green, Jennifer Linehan, Jane Choe, Ojas Shah, Arun Rai, Hristos Kaimakliotis, Isamu Tachibana, David Canes, Aaron Perecman, and Jay D Raman
INBRX-106: a hexavalent OX40 agonist that drives superior antitumor responses via optimized receptor clustering., Nisha Holay, Rashi Yadav, Sae Jeong Ahn, Melissa Kasiewicz, Anya Polovina, Annah S Rolig, Thi Staebler, Bryan Becklund, Noah D Simons, Yoshinobu Koguchi, Brendan P Eckelman, Yaiza Diaz de Durana, and William L. Redmond
Exploring decisional control preferences in older patients with cancer and their caregivers., Sofiia Hryniv, Elizabeth Gilbride, William Consagra, Supriya Mohile, Sule Yilmaz, Kaitlin Kyi, Sindhuja Kadambi, Marielle Jensen-Battaglia, Nikesha Gilmore, Mary Whitehead, Jamil Khatri, Fadi S Braiteh, Alison Conlin, Kah Poh Loh, and Allison Magnuson
Rechallenge With an Epidermal Growth Factor Receptor Inhibitor in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis., Amy H Huang, Gin Yi Lee, Chuan Angel Lu, Ibrahim Halil Sahin, Gentry T King, Rachael A Safyan, Stacey A Cohen, David B Zhen, Veena Shankaran, William P Harris, Andrew L Coveler, Jyoti Malhotra, Victoria E Forbes, Philip J Gold, E Gabriela Chiorean, and Ronan W Hsieh
The end of the genetic paradigm of cancer., Sui Huang, Ana M Soto, and Carlos Sonnenschein
A single-center experience of oncology rehabilitation to facilitate cardiopulmonary fitness recovery among breast cancer patients receiving chemotherapy, Mary Imboden, Hsin-Fang Li, E Koltner, Corrin Murphy, David B. Page, and Michael Layoun
Access to GLP-1s: Where Do Employers Fit in?, Mary T Imboden
Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma., Jana Ivanidze, Kellen Vo Vu, Rongwei Fu, Andrew Brandmaier, Laszlo Szidonya, Gagandeep Choudhary, Jay Starkey, Tony J Wang, Michael Sisti, L Guy McKhann, Sushant Puri, Marcus Konner, Michelle Roytman, Eaton Lin, Andrew Kuhn, Joseph R Osborne, Philip E Stieg, Kathryn Beal, Rohan R Ramakrishna, Gagandeep Singh, Angela Lignelli-Dipple, Mikhail Doubrovin, Anh Huan Vo, Mary Welch, Fabio Iwamoto, Aya Haggiagi, Laura Donovan, Maria Diaz, Brian Gill, Benjamin Liechty, David J Pisapia, Josh Walker, Rajiv S Magge, Matthew Wood, Valentina Marulanda Corzo, Olabisi R Sanusi, Ahmed Raslan, Aclan Dogan, Stephen Bowden, Sadek A Nehmeh, Joshua Nickerson, Nadine Mallak, Amber Ruiz, Prakash Ambady, Ali Nabavizadeh, and Ramon F Barajas
Real-world outcomes after discontinuation of covalent BTK inhibitor-based therapy in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma., Nitin Jain, Toby A Eyre, Katherine B Winfree, Naleen Raj Bhandari, Manoj Khanal, Tomoko Sugihara, Yongmei Chen, Paolo Abada, and Krish Patel
Pretraining Patient Foundation Models on Multimodal Patient Journeys, Daniel P Jeong, Suhana Bedi, Cliff Wong, Sheng Zhang, Jeya Maria Jose Valanarasu, Qianchu Liu, Reuben Tan, Zelalem Gero, Jaspreet Baga, Juan Manuel Zambrano Chaves, Naoto Usuyama, Hanwen Xu, Roshanthi Weerasinghe, Rom Leidner, Brian D. Piening, Carlo Bifulco, Tristan Naumann, and Hoifung Poon
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium., Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien, Ian Krop, Tiffany A Traina, Yara Abdou, Reva Basho, Alison K Conlin, Francisco J Esteva, Kevin R Fox, Vijayakrishna Gadi, Peter A Kaufman, Anya Litvak, Cynthia X Ma, Eleftherios P Mamounas, Heather McArthur, Kelly McCann, Zahi Mitri, Rebecca Shatsky, Melinda Telli, Mylin A Torres, and Kevin Kalinsky
Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer., Melissa L Johnson, Egbert F Smit, Enriqueta Felip, Suresh S Ramalingam, Myung-Ju Ahn, Anne Tsao, Bruce E Johnson, Michael Offin, Maen Hussein, Ibiayi Dagogo-Jack, Jonathan W Goldman, Jeffrey M Clarke, Marcelo V Negrao, Rachel E Sanborn, Daniel Morgensztern, Tiziana Usari, Keith Wilner, Linh Alejandro, Nada Rifi, Xiaosong Zhang, and Gregory J Riely
Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy., Mackenzie Jones, Zahraa W Alsafwani, Javier I J Orozco, Subodh M Lele, Mohd Wasim Nasser, Surinder K Batra, and Juan A Santamaria-Barria
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Neoadjuvant clinical trials in adults with newly diagnosed high-grade glioma: A systematic review., Tiffany M Juarez, Jaya M Gill, Boris R Minev, Akanksha Sharma, and Santosh Kesari
Evaluating Tumor Tissue Modified Viral (TTMV)-HPV DNA for the Early Detection of Anal Squamous Cell Carcinoma Recurrence., Rafi Kabarriti, Shane Lloyd, James Jabalee, Catherine Del Vecchio Fitz, Randa Tao, Tyler Slater, Corbin Jacobs, Sean Inocencio, Michael Rutenberg, Chance Matthiesen, Kasha Neff, Gene-Fu Liu, Tiffany M Juarez, and Stanley L Liauw
Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA., Rafi Kabarriti, Shane Lloyd, James Jabalee, Laurie M Gay, Tyler Slater, Kayleen Guzman, Corbin Jacobs, Sean Inocencio, Ray Lin, Cammie Nguyen, Iain MacEwan, Alexandra H Crawford, Michael Rutenberg, Jaswinder Singh, Jennifer Ross, Sophia Kim-Wang, Chance Matthiesen, Kasha Neff, Gene-Fu Liu, Tiffany Juarez, and Stanley L Liauw
Epigenetic Regulation of OLIG2 in Glioblastoma: Mechanisms and Therapeutic Targets to Combat Treatment Resistance., Sanya Kapoor, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Efficacy of Endoscopic Full Thickness Resection Using the Full-Thickness Resection Device for Submucosal Invasive Colorectal Cancer: The First United States Multicenter Experience., Rahul Karna, Syed Kashif Mahmood, Jennifer Phan, Sumant Inamdar, Antonio Mendoza Ladd, Veeral M Oza, Mohit Girotra, Harshit Khara, Natalie Wilson, Nabeel Azeem, and Mohammad Bilal
Radiation therapy causes a STING and MyD88-independent upregulation of CD80 and CD86 in macrophages and monocytes that limits tumor control., Aanchal Preet Kaur, Jason R Baird, Alejandro F Alice, Gwen Kramer, David Friedman, Eva Moran, Marka R Crittenden, and Michael J. Gough
Commentary: Molecular responses in pig heart to human xenotransplantation unveiled by longitudinal multi-omic profiling., Brendan J Keating, Eloi Schmauch, Michael P Snyder, Jennifer D Motter, and Brian D. Piening
Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program., Grace Keegan, Joseph Ravenell, Angelena Crown, Charles DiMaggio, and Kathie-Ann Joseph
Metastatic Melanoma Outcomes and the Evolving Role of Surgery in the Immunotherapy Era., Hilary R Keller, Douglas A Hanes, Jillian K McCabe, Danny Lascano, Paul Shin, Melanie Goldfarb, and Richard Essner
Results of a phase II trial of short-course radiation and TASOX [trifluridine/tipiracil (TAS-102) plus oxaliplatin] chemotherapy in operable rectal cancer., H F Kennecke, J A Zell, H Pham, V V Simianu, K Herz, A Kelley, J C Carmichael, H Hochster, and L A Kachnic
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy., Mohamed A Kharfan-Dabaja, Ambuj Kumar, Javier Pinilla-Ibarz, Jennifer R Brown, Mazyar Shadman, Farrukh T Awan, Saad S Kenderian, Tanya Siddiqi, Jeremy S Abramson, Taha Al-Juhaishi, Danielle M Brander, Catherine C Coombs, Richard R Furman, Nitin Jain, Nadia Khan, Nakhle S Saba, Jennifer M Collins, Amer Beitinjaneh, Deborah M Stephens, Jennifer Woyach, and Mehdi Hamadani
Machine Learning Model Predictors of Intrapleural Tissue Plasminogen Activator and DNase Failure in Pleural Infection: A Multicenter Study., Danai Khemasuwan, Candice Wilshire, Chakravarthy Reddy, Christopher Gilbert, Jed Gorden, Akshu Balwan, Trinidad M Sanchez, Billie Bixby, Jeffrey S Sorensen, and Samira Shojaee
Tumor Microenvironment Lactate: Is It a Cancer Progression Marker, Immunosuppressant, and Therapeutic Target?, Eugene Y Kim, Joyce Abides, Chandler R Keller, Steve R Martinez, and Weimin Li
Cancer care disparities among patients with limited English proficiency: challenges and strategies for equity., Hye Sung Kim, Carly Irwin, Arjun S Ulag, and Siddhartha Devarakonda
Impact of Patient Positioning and Endotracheal Intubation During ERCP: Insights from a Large Database., Divyanshoo R Kohli, Nishant Puri, Douglas A Hanes, Jack Brandabur, and Wichit Srikureja
Correction: CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny., Garth L Kong, Thai T Nguyen, Wesley K Rosales, Anjali D Panikar, John H W Cheney, Theresa A Lusardi, William M Yashar, Brittany M Curtiss, Sarah A Carratt, Theodore P Braun, and Julia E Maxson
Endothelial cells as targets of immune checkpoint blockade., Alan J Korman, Matthew H Taylor, and F Stephen Hodi
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study., Matthew G Krebs, Byoung Chul Cho, Sandrine Hiret, Ji-Youn Han, Ki Hyeong Lee, Casilda Llácer Pérez, Filippo De Braud, Eric B Haura, Rachel E Sanborn, James Chih-Hsin Yang, Catherine A Shu, Koichi Goto, Makoto Nishio, Jun Zhao, Zhijie Wang, Pascale Tomasini, Enriqueta Felip, Jonathan W Goldman, Sai-Hong Ignatius Ou, Michael Boyer, Grace Gao, Siyang Qu, Joshua C Curtin, Xuesong Lyu, Robert W Schnepp, Priya Kim, Meena Thayu, Roland E Knoblauch, Patricia Lorenzini, Mahadi Baig, Alexander I Spira, and Natasha B Leighl
Long-term oncologic outcomes and complications of robot-assisted radical cystectomy for the treatment of urothelial carcinoma of the bladder., Daniel J Lama, Oluwatimilehin Okunowo, Jonathan Yamzon, Ali-Asghar Zhumkhawala, Timothy G Wilson, Clayton S Lau, Bertram E Yuh, and Kevin G Chan
Low rates of cardiotoxicity during HER2-directed antibody therapy for breast cancer across a large, Western US hospital system, Michael Layoun; David B Page; Hsin-Fang Li; Cameron Smith, DO, MPH; E Koltner; Mary Imboden; Zachary Taylor; and Kateri Spinelli
Lessons learned in migrating from one commercial genetics clinical decision-making tool to another: Assessment of data integrity and utilization., Calvin Le, Kevin Tatunay, Wayne Liu, Haibo Lu, Nicole-Ann Rodis, Thomas Nam, Mercy Y Laurino, and Marianne E Dubard-Gault
Linvoseltamab in Patients With Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses., Hans C Lee, Jeffrey A Zonder, Madhav V Dhodapkar, Sundar Jagannath, James E Hoffman, Attaya Suvannasankha, Mansi R Shah, Suzanne Lentzsch, Rachid Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Michelle DeVeaux, Tito Roccia, Dhruti Chokshi, Megan Seraphin, Kate Knorr, Anita Boyapati, Anasuya Hazra, Karen Rodriguez Lorenc, Glenn S Kroog, Naresh Bumma, and Joshua Richter
Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer., Kyle Lee, Angela Pallesi, Betsy Valdez, Douglas A Hanes, Estela Samuels, Stacey Stern, Nicketti Handy, Crystal E Fancher, Javier I Orozco, and Janie Grumley
3D Brain Vascular Niche Model Captures Glioblastoma Infiltration, Dormancy, and Gene Signatures., Vivian K Lee, Rut Tejero, Nathaniel Silvia, Anirudh Sattiraju, Aarthi Ramakrishnan, Li Shen, Alexandre Wojcinski, Santosh Kesari, Roland H Friedel, Hongyan Zou, and Guohao Dai
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve, Xiuning Le, Jyoti D Patel, Elaine Shum, Christina Baik, Rachel E Sanborn, Catherine A Shu, Chul Kim, Mary Jo Fidler, Richard Hall, Yasir Y Elamin, Janet Tu, George Blumenschein, Jianjun Zhang, Don Gibbons, Carl Gay, Nisha A Mohindra, Young Chae, Yanis Boumber, Joshua Sabari, Rafael Santana-Davila, Shane Rogosin, Benjamin Herzberg, Ben Creelan, Bruna Pellini, Tawee Tanvetyanon, Simon Heeke, Mike Hernandez, Jhanelle E Gray, Andreas Saltos, and John V Heymach
Alterations of the composition and spatial organization of the microenvironment following non-dysplastic Barrett's esophagus through progression to cancer., Meng-Lay Lin, John W Hickey, Adam Passman, Emanuela Carlotti, Shruthi Devkumar, Yannick H Derwa, Joanne ChinAleong, Richard J Hackett, James Evans, Veena Sangwan, Marco R Novelli, Manuel Rodriguez Justo, Nicholas A Wright, Marnix Jansen, Tim J Underwood, Sui Huang, Philippe Gascard, Mairi H McLean, Christian M Schürch, Thea D Tlsty, Lorenzo Ferri, Garry P Nolan, and Stuart A C McDonald
Asia's emergence in cancer immunotherapy: challenges and opportunities., Yan Li, Joe Yeong, Bernard A Fox, and Cheng Sun
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial., Juanita Lopez, Thomas Powles, Fadi Braiteh, Lillian L Siu, Patricia LoRusso, Claire F Friedman, Ani S Balmanoukian, Michael Gordon, Jeffrey Yachnin, Sylvie Rottey, Ioannis Karydis, George A Fisher, Marcus Schmidt, Martin Schuler, Ryan J Sullivan, Howard A Burris, Vladimir Galvao, Brian S Henick, Luc Dirix, Dirk Jaeger, Patrick A Ott, Kit Man Wong, Guy Jerusalem, Aglaia Schiza, Lawrence Fong, Neeltje Steeghs, Rom Leidner, Achim Rittmeyer, Scott A Laurie, Eelke Gort, Raid Aljumaily, Ignacio Melero, Rachel L Sabado, Ina Rhee, Michael R Mancuso, Lars Muller, Gregg D Fine, Mahesh Yadav, Leesun Kim, Vincent J P Leveque, Alberto Robert, Martine Darwish, Ting Qi, Jiawen Zhu, Jingbin Zhang, Patrick Twomey, Gautham K Rao, Donald W Low, Chris Petry, Amy A Lo, Jill M Schartner, Lélia Delamarre, Ira Mellman, Martin Löwer, Felicitas Müller, Evelyna Derhovanessian, Andrea Cortini, Luisa Manning, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Tana Omokoko, Eva Godehardt, Dirk Becker, Christine Hawner, Christine Wallrapp, Christian Albrecht, Christoph Kröner, Arbel D Tadmor, Jan Diekmann, Mathias Vormehr, Anette Jork, Anna Paruzynski, Maren Lang, Jonathon Blake, Oliver Hennig, Andreas N Kuhn, Ugur Sahin, Özlem Türeci, and D Ross Camidge
Updates in Management of Locally and Regionally Advanced Basal Cell Carcinoma., Kristel Lourdault, Brett Crosby, Jillian McCabe, and Richard Essner
A pilot survey into the landscape of neuro-oncology care in the community., Christine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, Akanksha Sharma, Yazmin Odia, Brian Vaillant, Charles Redfern, Aaron Mammoser, Kent Shih, Santosh Kesari, Richard Peterson, Bret Friday, W Jeffery Edenfield, Sebastian Koga, James Snyder, Jerry Jaboin, Isaac Melguizo-Gavilanes, Melissa McCabe, Michael Humeniuk, Prakash Ambady, and Erin Dunbar
In Regard to Aly et al., Join Y Luh
Telehealth in Radiation Oncology: Time to Refine, Not Just Expand., Join Y Luh
Estimation of the value-based price of a blood test for Alzheimer's disease pathology in primary and specialty care in the U.S., Soeren Mattke, Jiahe Chen, Mark Hanson, Kim G Johnson, Cara Leahy, David A Merrill, Victoria Shada, and Jorge G Ruiz
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence., Francesco Mazziotta, Lauren E Martin, Daniel N Egan, Merav Bar, Sinéad Kinsella, Kelly G Paulson, Valentin Voillet, Miranda C Lahman, Daniel Hunter, Thomas M Schmitt, Natalie Duerkopp, Cecilia C S Yeung, Tzu-Hao Tang, Raphael Gottardo, Yuta Asano, Elise C Wilcox, Bo Lee, Tianzi Zhang, Paolo Lopedote, Livius Penter, Catherine J Wu, Filippo Milano, Philip D Greenberg, and Aude G Chapuis
Implementation of a lisocabtagene maraleucel chimeric antigen receptor T-cell therapy outpatient monitoring program: Multicenter nursing/advanced practice provider perspectives., Nicole McEntee, Jacqueline Manago, ChiaChun Lu, and Lucy Holmes
